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Executive Summary
Catheter associated urinary tract infections (CAUTI) are a common preventable
occurrence in healthcare. With many conditions requiring catheterization for numerous reasons,
catheter use is unavoidable in many circumstances. According to Sun et al., (2020), catheters
account for up to 80% of hospital-acquired infections. This paper discusses how proper catheter
selection in addition to a series of nursing interventions can decrease CAUTI. The benchmark
project will address the steps of data analysis, protocol approval, staff education,
implementation, and post implementation data analysis. The previous 12 months of data on
CAUTI rate, CAUTI mortality rate, number of catheter days, current protocols in place for
catheter insertion/discontinuation, and catheter selection will be carefully reviewed. The data
analysis will be presented to Administration for review and approval of a new protocol to
decrease CAUTI rate. Once approved, nursing staff and physicians will be educated on the new
protocol for catheterization. The new protocol will consist of using only silver-alloy catheters,
allowing the nurse to initiate and discontinue the catheter according to the protocol without
having to contact the physician. There will be specific diagnoses that will exclude the patient
from this protocol. The nurse will also document the catheter status and bag location, urine
quality, quantity, and amount twice per shift. The nurse will also be required to report changes in
WBC’s (white blood cells) on lab work and report abnormalities in UA’s (urinalysis) to the
physician. The aim of the new protocol is to decrease CAUTI incidence, improve patient
outcomes, decrease CAUTI mortality, decrease the number of catheter days, increase revenue,
prevent loss of revenue from negative outcomes, and to maintain and elevate facility quality
measures. The new protocol will be implemented for 12 months before the data is reanalyzed for
the results, which will likely show improved CAUTI rates and improved patient outcomes.
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Catheter Associated Urinary Tract Infections: A Benchmark Study
Foley catheters are a common nursing intervention for a variety of diagnoses. Catheterassociated urinary tract infections (CAUTI) are a common complication of patients with
indwelling catheters and a leading cause of hospital acquired infections (Sun et al., 2020). This
paper discusses how CAUTI incidence can be decreased by catheter selection and a series of
nursing interventions. In (P) patients requiring catheterization, (I) do silver containing catheters
(C) compared to non-silver containing catheters (O) decrease catheter associated infections over
a (T) 12-month period?
Rationale for the Project
This benchmark project will evaluate how the use of antimicrobial urinary catheters along
with certain nursing interventions decrease catheter associated urinary tract infection (CAUTI).
Catheters are a common occurrence in many aspects of nursing. In the home setting, nurses most
commonly see Foley catheters used for a variety of reasons. Urinary tract infection prevention is
a crucial part of every patient who requires catheterization on a long- or short-term basis.
Catheter-associated urinary tract infection (CAUTI) represents one of the most common causes
of morbidity and mortality. Prolonged catheterization is an important risk factor associated with
CAUTI, and the formation of biofilm plays a central role in the pathogenesis of CAUTIs. Silvercoated catheters show promise toward reducing CAUTI (Cooper et al., 2016). Healthcare
professionals have a major responsibility to do the right thing for the patient and present the best
treatment options as applicable. The goal of ascertaining whether silver-alloy catheters are
superior to standard latex catheters is to ensure care provided is the best available and driven by
the evidence. Currently, the protocol for indwelling catheters is to use standard siliconeelastomer latex Foley catheters unless there is a contraindication to latex, and in that case a
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silicone catheter would be used. In the home setting, catheters are changed every 4 weeks and as
needed for leakage, dislodgement, or blockage. Catheter bags are to be emptied every 12 hours
unless more frequent emptying is necessary. Patients and families are instructed on catheter care
including daily cleansing of the meatus, maintaining bag position below the bladder- but not on
the floor, and signs and symptoms of infection to report such as fever, chills, sweating, foul odor,
or changes in mental status. Current practice is to collect a urinalysis only after contacting the
physician and obtaining a verbal order. There are currently no alternatives to catheterization as
the Foley catheter is the only viable option for short term and long-term needs (Feneley et al.,
2015), so preventing CAUTI is an important issue.
Literature Synthesis.
Collectively, the research suggests that silver containing catheters do decrease CAUTI,
but this alone is not always effective. Chung et al. (2017) concluded that a 31% reduction was
seen in patients with the silver and hydrogel catheters. A study by Aljohi et al., (2016)
demonstrated a 90% decrease in CAUTI using noble metal alloy catheters in the ICU. Clarke et
al. (2012) concluded that bundling interventions can provide cost savings, decreased CAUTI
rate, and better patient outcomes. Ackam et al., (2019) state that a small number of patients with
antimicrobial catheters have demonstrated a decrease in CAUTI. Magnusson et al., (2019)
reported a decrease in the frequency of recurrent UTI with noble metal alloy catheters.
According to Johnson et al., (2016), a 28% reduction in CAUTI was seen postimplementation of
an eight-month long trial of a nurse driven catheter protocol. Lederer et al., (2014) conducted a
multicenter, before-after cohort study of patients with CAUTI yielded a 41-58% reduction. The
study compared the infection rates while using standard catheters for 3 months and silver-alloy
catheters for 3 months. Lederer et al. (2014) concluded with a 95 percent confidence interval that

CATHETER ASSOCIATED INFECTIONS

7

the infection rate decreased with the use of silver-alloy catheters. Beattie & Taylor (2011)
conducted a systematic review (SR) of 97 studies that showed likelihood that silver alloy
catheters decrease CAUTI. Cooper et al., (2016) tested the antimicrobial ability of photodeposited silver on urinary catheters and the results suggest that silver is antimicrobial. Sun et al.,
(2020) concluded with their systematic review that bacteremia was reduced with the use of
silver-alloy catheters. These studies are the “gold standard” level 1 evidence (Fineout-Overholt
& Stillwell, 2019). Johnson et al., (2016) estimate that 30-40% of patients do not receive care
based on the best available evidence. The evidence is clear suggesting that the use of silver-alloy
catheters in addition to certain nursing interventions can have a substantial decrease on CAUTI.
Project Stakeholders
. The stakeholders impacted by the change will be patients, nurses, physicians, facility
administrators, financial shareholders, and Centers for Medicare and Medicaid (CMS). Each
stakeholder will be impacted by the change because of the role infection rate in all aspects of
care including comparative ratings and reimbursement. CMS adjusts payment to involved
entities-hospitals, skilled nursing facilities, home health agencies-when readmissions occur for
the same diagnosis within set time frames (CMS, 2020). Stakeholders all want to have lower
infection rate, lower costs, and fewer complications related to Foley catheter use. The ethical
considerations are autonomy and beneficence. Patients have a legal right to choose treatment and
must be provided with all options available and be able to weigh the pros and cons to make an
informed decision. Nurses should inform patients of the new protocol in place to reassure
patients that they are receiving the most current treatment with the least amount of
complications. Most patients elect treatment that is aligned with their own values and beliefs and
nurses have the responsibility to facilitate this autonomy (American Nurses Association, 2015).
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Implementation Plan
Most processes of change are met with resistance from one source or another. The
challenge will be to overcome nurse resistance. Many people are used to doing things a certain
way and respond best to change when the “why” is provided. Nursing staff will be provided with
education regarding catheter selection, insertion and removal timing, and monitoring
interventions all in effort to reduce CAUTI according to the evidence. Johnson et al. (2016), state
that evidence-based education makes nursing more caring because care is based on the evidence
resulting in better care and outcomes. Most nurses will support change if they believe it will
benefit their patients, so this will be the most important part of having this change embraced. To
evaluate the success of the change, the previous 12 months of data will be examined and
compared to the infection rates of the implementation period. The goal of the change project is to
decrease CAUTI. The project will involve a series of interventions by nursing staff implemented
at designated times such as immediately prior to surgical procedures, or as indicated by certain
diagnoses that result in urinary retention. The nurse will initiate the silver-alloy catheter as
indicated and discontinue it when no longer indicated. The nurse will also document the location
of the drainage bag and catheter, urine characteristics, & amount in addition to monitoring and
reporting any elevation in white blood cells on lab work and any abnormal findings on urinalysis
and documenting vital signs twice per shift. These interventions will allow each nurse to take
ownership for preventing CAUTI. CAUTI is an important part of nursing no matter the setting,
so to find an evidence-based solution for preventing them could change healthcare.
Timetable/Flowchart
The timetable for the project is listed in Figure 1. The benchmark project will take place
over a 2-year period. The project began with the formulation if the PICOT (population,
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intervention, comparison, outcome, time) question. The previous 12 months of data will be
analyzed for CAUTI infection rates, CAUTI mortality rates, number of catheter days, current
protocols in place for catheterization, and process for catheter selection. Once the data is
analyzed, the results will be presented to administration. During the results presentation, the
request for a change in protocol will be presented for approval. This process takes 2-3 months
and once approval is obtained, an implementation plan will be presented. Once approval is
obtained within 90 days, the education process will start. Nurses and physicians will be educated
on the new protocol for initiating and discontinuing catheters. The new protocol will be
implemented.
Figure 1

Data Collection Methods
The pre-implementation data will be comprehensively evaluated for the previous 12
months’ CAUTI rates. The results review will be comprehensive to include all patients on the
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unit who had a catheter during the timeframe. The researchers will evaluate the outcomes for
each patient to determine if there were complications from the catheterization such as
rehospitalization, sepsis, or mortality. The researchers will evaluate the additional costs of
treatment for any complications related to CAUTI. Any negative ramification to the facility from
CAUTI will be analyzed including any decreases in quality ratings, negative reporting, or loss in
reimbursement. The cost of care for patients with CAUTI will be evaluated to identify cost
savings or elevations because of the implementation. The researchers will calculate the number
of catheter days during the 12-month period to establish a baseline prior to the new protocol
implementation. The data will be examined to determine the CAUTI rate per 365 days. Once the
protocol is implemented for 12 months, the same data for the implementation period will
evaluated and compared.
Cost/Benefit Discussion
UTI’s are a common occurrence in health care. Catheter coating and specific nursing
interventions have been shown to decrease the rate of CAUTI. The most basic methods of
preventing CAUTI using catheters only when necessary, for the shortest amount of time, and
with the best aseptic technique. The cost of treating CAUTI is about $400 million/year. Lederer
et al., (2011) reports a $3,800 increase per patient with CAUTI. The implementation cost will
average around $6,500 to implement. The new protocol pays for itself by preventing two patients
from getting CAUTI. With rising health care costs, CAUTI can be prevented. Along with pain,
CAUTIs can extend hospital stays and increase use of antibiotics, increasing the likelihood of
resistant strains of bacteria. Some common complications are cystitis, pyelonephritis, sepsis,
shock, and possibly death. Septic shock has an extremely high mortality rate, making early
treatment and prevention of CAUTI crucial (Aljohi et al., 2016).
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Discussion of Results
The project is an anticipated success as the data analysis post implementation is expected
to show a decrease in CAUTI rate, decreased mortality rates, improved patient outcomes, lower
costs, and decreased catheter days. Decreasing the days patients have a catheter inserted will also
decrease the likelihood that they develop an infection. Consequently, patients return and
recommend facilities that provided excellent service, care, and less complications. This will
result in better satisfaction scores and outcome ratings, which also will result in higher
reimbursement and revenue. CMS decreases payment to facilities that do not provide minimum
standards of care. Once the project can be implemented in a time post the novel Coronavirus
2019, one will be able to analyze real data and show with high certainty that silver catheters and
a series of nursing interventions do decrease CAUTI.
Conclusions/Recommendations
Based on the conclusions from the research, silver catheters should be implemented with
the nursing interventions to decrease CAUTI on a widescale basis. Patient outcomes will improve,
costs will be lowered, and less revenue will be recuperated as a result. The next step for the project
is implementation. For those who require an indwelling catheter, whether short- or long-term, the
Foley catheter is and has been the standard of care, despite the ability to cause bacterial
colonization, recurrent and chronic infections, a host of other complications and contribute to
antibiotic resistance (Feneley, et al., 2015). Clinicians must continue to challenge the status quo
and seek the best evidence for patient care.
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Synthesis Table

Citation: (i.e., author(s), date of
publication, & title)
Author, Year, Title

Conceptual Framework
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Method

Theoretical basis for study
Qualitative
Tradition

Sample/
Setting
Number,
Characteristi
cs,
Attrition rate
& why?

Major
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Studied and
Their
Definitions
Independent
variables
(e.g., IV1 =
IV2 =)
Dependent
variables
(e.g., DV = )
Do not need
to put IV &
DV in
Legend

Measurement
of Major
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Data
Analysis

Study Findings

Strength of the Evidence (i.e., level of evidence + quality
[study strengths and weaknesses])
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were used to
measure the
outcome
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name of scale,
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the clinical
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all stats do not
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into the table)

Statistical findings or
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statistical test you
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finding)
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• Risk or harm if study intervention or findings
implemented
• Feasibility of use in your practice
• Remember: level of evidence (See PICOT handout) +
quality of evidence = strength of evidence & confidence to
act
• Use the USPSTF grading schema
http://www.ahrq.gov/clinic/3rduspstf/ratings.htm

Bonfill et al, (2017). Efficacy and
safety of urinary catheters with silver
alloy coating in patients with spinal
cord injury: a multicentric pragmatic
randomized controlled trial. The
ESCALE trial.

None Stated

Open label,
multicenter
RCT

N=489
14 hospitals
Age 18+
Cath 7+ days
Traumatic or
medical
SCI

IV=SAH
catheter
DV=sympto
matic UTI
DV2=Bacter
emia &
adverse
events

Positive urine
culture
Fever >38.0 C
CV pain,
tenderness, foul
smelling odor,
sweating, AD,
dysuria

Symptomatic
UTI-OR 0.96
(0.49-1.87)
Experimental
group adverse
events OR 0.03
(0.00-0.06)
95% CI

More research needed
to support SAH
effectiveness in SCI’s

Strengths: Level 2 RCT, decreased CAUTI in hospitalized pt’s
less than 7 day cath, assessor blinded to intervention, clear
inclusion/exclusion criteria.
Weaknesses: Specific to SCI, not as specific to hospitalized
patients, clinicians not blinded to intervention, participants
allowed to be randomized more than once, only some received
prophylactic abx, premature termination of study.
Feasibility: Yes
Grade C, Moderate Level of Certainty, Level 2 RCT

Clarke et al., (2012). Reduction in
catheter-associated urinary tract
infections by bundling interventions.

None Stated

Retrospectiv
e cohort

N=2228
Indwelling
Cath in
post
interventio
n period
WGMC

CDC NHSN
Definition of
CAUTI

GEE regression
analysis

Suggests SAH
decreases CAUTI
Decreases costs

Strengths: adequate effect size to be generalized, study can be
reproduced in other facilities, 1st study to add 4 interventions,
includes decreased CAUTI rate & true cost reduction, IV’s
Category 1B recommendations
Weaknesses: Not a Level 1 SR of RCT, study from only one
facility, each intervention effect not studied individually
Feasibility: Yes
Grade A, High Level of Certainty, Level 4 Cohort

Beattie & Taylor, (2011). Silver alloy
vs. uncoated urinary catheters: A
systematic review of the literature.

None Stated

Systematic
Review
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Adult
Requires short
term urinary
catheterization
Outcome
measures
SAH vs non
SAH
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e SAH use
IV2=CSD
IV3=Cath
bag off floor
DV=CAUTI
rate
DV2=CAUT
I cost rate
IV=SAH vs
non SAH or
teflon
catheter
DV=CAUTI
decreased

CASP-SRT
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detection
methods

Fischer’s Exact
test, Chi Square,
Kaplan-Meier &
Student’s t-test

Suggests SAH
decreases CAUTI
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Weaknesses: moderate evidence and significant heterogeneity of
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e Cohort
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Age-18-89
foley cath
insertion
culture with
<2 organism
7 acute care
hospitals

IV=silver vs
standard cath
DV=CAUTI
infection rate

Fisher’s Exact
Wilcoxon’s

OR 0.53
P < 0.0001
95% CI 0.45-0.6

SAH decreased
CAUTI’s by NHSN &
clinical criteria

Strengths: Assess both NHSN and clinical criteria definition of
CAUTI, captured all cultures in the time period
Weaknesses: Not a Level 1 SR of RCT, sponsored by Bard,
limited to documentation because of retrospectiveness, device
days & patient days show correlation
Feasibility: Yes
Grade A, High Level of Certainty, Level 4 Cohort

None Stated

Prospective
single
facility RCT

N=95
12 M study at
UMMC
Attrition=no
post cath ua,
no qd ua, or
in/exclusion
criteria not
met

IV= test
silver cath
DV=time to
ABU

Urine dipstick
qd & after 48 H
post cath dc
Monitoring v/s,
s/p tenderness,
dysuria, itching,
redness,
swelling,
dysuria, or
oliguria

P=0.08, log-rank
test ABU test
group
P=0.03 ABU
total population

Time to ABU
decreased by test
catheter

Strengths: Assesses time to ABU for test silver system vs
standard silver system, RCT, results warrant more studies, 0
ABU in test group, study design was FDA mandated
Weaknesses: small sample size, single facility study, pilot study,
results warrant more studies, only 63% completed study per
protocol
Feasibility: Yes
Grade C, Moderate Level of Certainty, Level 2 RCT

Lederer, Jarvis, Thomas, & Ritter,
(2011). Multicenter cohort study to
assess the impact of a silver-alloy and
hydrogel-coated urinary catheter on
symptomatic catheter-associated
urinary tract infections.

Leuck, et al., (2015). Safety and
efficacy of a novel silver-impregnated
urinary catheter system for preventing
catheter-associated bacteriuria: A
pilot randomized clinical trial.
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Legend: N=Number of Participants OR=Odds Ratio P=Level of Significance CI=Confidence Interval SAH=Silver Alloy Hydrogel Catheter IV=Independent Variable DV=Dependent
Variable CAUTI=Catheter Associated Urinary Tract Infection NHSN= National Healthcare Safety Network RCT=Randomized Controlled Trial UMMC=University of Minnesota Medical
Center M=Month ABU=asymptomatic bacteriuria, qd=daily s/p=suprapubic v/s=vital signs SR=Systematic Review CASP= Critical Appraisal Skills Programme SRT=Systematic Review
Tool RCTT=Randomized Controlled Trial Tool CSD=Catheter Securement Device WGMC=West Georgia Medical Center CDC= Center for Disease Control NHSN=National Safety &
Health Network AD=Autonomic Dysreflexia, CV=costovertebral SCI=Spinal Cord Injury ABX= Antibiotics GEE=General Estimation Equation
***Prompts for each column – please do not repeat the headings, just provide the data
Used with permission, © 2007 Fineout-Overho
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